Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 29, 2017 | $8.50B |
| FY2017, ended Jan 28, 2018 | $9.94B |
| FY2018, ended Feb 3, 2019 | $18.0B |
| FY2019, ended Feb 2, 2020 | $29.7B |
| FY2020, ended Jan 31, 2021 | $41.1B |
| FY2021, ended Jan 30, 2022 | $38.8B |
| FY2022, ended Jan 29, 2023 | $37.9B |
| FY2023, ended Jan 28, 2024 | $57.8B |
| FY2024, ended Feb 2, 2025 | $47.8B |
| FY2025, ended Feb 1, 2026 | $19.3B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $12.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 29, 2017 | $2.34B |
| FY2017, ended Jan 28, 2018 | $2.65B |
| FY2018, ended Feb 3, 2019 | $3.29B |
| FY2019, ended Feb 2, 2020 | $3.98B |
| FY2020, ended Jan 31, 2021 | $4.40B |
| FY2021, ended Jan 30, 2022 | $6.26B |
| FY2022, ended Jan 29, 2023 | $8.11B |
| FY2023, ended Jan 28, 2024 | $9.62B |
| FY2024, ended Feb 2, 2025 | $10.6B |
| FY2025, ended Feb 1, 2026 | $11.1B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $11.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 29, 2017 | $303M | $237M |
| FY2017, ended Jan 28, 2018 | $259M | $331M |
| FY2018, ended Feb 3, 2019 | $484M | $517M |
| FY2019, ended Feb 2, 2020 | $646M | $386M |
| FY2020, ended Jan 31, 2021 | $589M | $574M |
| FY2021, ended Jan 30, 2022 | $975M | $995M |
| FY2022, ended Jan 29, 2023 | $855M | $328M |
| FY2023, ended Jan 28, 2024 | $1.55B | $1.64B |
| FY2024, ended Feb 2, 2025 | $1.81B | $1.58B |
| FY2025, ended Feb 1, 2026 | $1.58B | $922M |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $1.42B | $1.35B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 29, 2017 | $735M |
| FY2017, ended Jan 28, 2018 | $991M |
| FY2018, ended Feb 3, 2019 | $881M |
| FY2019, ended Feb 2, 2020 | $1.09B |
| FY2020, ended Jan 31, 2021 | $1.15B |
| FY2021, ended Jan 30, 2022 | $1.26B |
| FY2022, ended Jan 29, 2023 | $1.15B |
| FY2023, ended Jan 28, 2024 | $2.24B |
| FY2024, ended Feb 2, 2025 | $1.98B |
| FY2025, ended Feb 1, 2026 | $1.81B |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $1.39B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 29, 2017 | — |
| FY2017, ended Jan 28, 2018 | — |
| FY2018, ended Feb 3, 2019 | — |
| FY2019, ended Feb 2, 2020 | $0 |
| FY2020, ended Jan 31, 2021 | $0 |
| FY2021, ended Jan 30, 2022 | $0 |
| FY2022, ended Jan 29, 2023 | $0 |
| FY2023, ended Jan 28, 2024 | $0 |
| FY2024, ended Feb 2, 2025 | $0 |
| FY2025, ended Feb 1, 2026 | — |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $0 |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 17.0% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 29, 2017 | 127M |
| FY2017, ended Jan 28, 2018 | 126M |
| FY2018, ended Feb 3, 2019 | 123M |
| FY2019, ended Feb 2, 2020 | 124M |
| FY2020, ended Jan 31, 2021 | 125M |
| FY2021, ended Jan 30, 2022 | 123M |
| FY2022, ended Jan 29, 2023 | 122M |
| FY2023, ended Jan 28, 2024 | 121M |
| FY2024, ended Feb 2, 2025 | 116M |
| FY2025, ended Feb 1, 2026 | 110M |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | 106M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Jan 29, 2017 | $29.3M | $16.8M |
| FY2017, ended Jan 28, 2018 | $100M | $17.6M |
| FY2018, ended Feb 3, 2019 | $598M | $28.6M |
| FY2019, ended Feb 2, 2020 | $173M | $45.6M |
| FY2020, ended Jan 31, 2021 | $63.7M | $50.8M |
| FY2021, ended Jan 30, 2022 | $813M | $69.1M |
| FY2022, ended Jan 29, 2023 | $444M | $78.1M |
| FY2023, ended Jan 28, 2024 | $559M | $93.6M |
| FY2024, ended Feb 2, 2025 | $1.64B | $90.0M |
| FY2025, ended Feb 1, 2026 | $1.18B | $62.2M |
| Trailing 12 months to Aug 2, 2026 (through Q2 FY2026) | $1.16B | $91.2M |
Valuation
At current price- Market Cap
- $11.0B
- P/E
- 7.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.0×
- Price / Book
- 2.3×
- EV / EBITDA
- 3.8×
Growth
Trailing 12 months- Revenue (TTM)
- $11.1B
- Revenue Growth YoY
- 1.7%
- Revenue CAGR 3Y
- 11.0%
- Revenue CAGR 5Y
- 20.3%
- EPS Growth YoY
- −17.1%
- Net Income Growth YoY
- −20.6%
Profitability
Trailing 12 months- Gross Margin
- 56.1%
- Operating Margin
- 17.8%
- Net Margin
- 12.8%
- FCF Margin
- 12.2%
- Return on Equity
- 30.9%
Earnings
Trailing 12 months- Net Income
- $1.42B
- EPS (diluted)
- $12.15
- EBITDA
- $2.52B
- Operating Income
- $1.98B
Balance Sheet
As of Aug 2, 2026- Cash and cash equivalents
- $1.39B
- Total Debt
- $0
- Net Cash
- $1.39B
- Total Assets
- $8.48B
- Total Liabilities
- $3.69B
- Shareholders' Equity
- $4.79B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $1.98B
- Capital Expenditure
- $628M
- Free Cash Flow
- $1.35B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.91
Every ratio is calculated from the company’s reported figures.